CoChat
Sign Up
Cited by 1,336Global Public Health Policies and EpidemiologyHealthcare Systems and Public HealthGlobal Health and Epidemiology

The DOI matches its Crossref record; 109 of the 113 references it cites were found in a registry or an index.

NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4

Open access
Bennett, James E, Stevens, Gretchen A, Mathers, Colin D, Bonita, Ruth, Rehm, Jürgen, Kruk, Margaret E, Riley, Leanne M, Dain, Katie, Kengne, Andre P, Chalkidou, Kalipso, Beagley, Jessica, Kishore, Sandeep P, Chen, Wanqing, Saxena, Shekhar, Bettcher, Douglas W, Grove, John T, Beaglehole, Robert, Ezzati, Majid·2018·The Lancet
DOI 10.1016/s0140-6736(18)31992-5
Open this paper in CoChat — free accountOpen PDF

Abstract

The third UN High-Level Meeting on Non-Communicable Diseases (NCDs) on Sept 27, 2018, will review national and global progress towards the prevention and control of NCDs, and provide an opportunity to renew, reinforce, and enhance commitments to reduce their burden. NCD Countdown 2030 is an independent collaboration to inform policies that aim to reduce the worldwide burden of NCDs, and to ensure accountability towards this aim. In 2016, an estimated 40·5 million (71%) of the 56·9 million worldwide deaths were from NCDs. Of these, an estimated 1·7 million (4% of NCD deaths) occurred in people younger than 30 years of age, 15·2 million (38%) in people aged between 30 years and 70 years, and 23·6 million (58%) in people aged 70 years and older. An estimated 32·2 million NCD deaths (80%) were due to cancers, cardiovascular diseases, chronic respiratory diseases, and diabetes, and another 8·3 million (20%) were from other NCDs. Women in 164 (88%) and men in 165 (89%) of 186 countries and territories had a higher probability of dying before 70 years of age from an NCD than from communicable, maternal, perinatal, and nutritional conditions combined. Globally, the lowest risks of NCD mortality in 2016 were seen in high-income countries in Asia-Pacific, western Europe, and Australasia, and in Canada. The highest risks of dying from NCDs were observed in low-income and middle-income countries, especially in sub-Saharan Africa, and, for men, in central Asia and eastern Europe. Sustainable Development Goal (SDG) target 3.4-a one-third reduction, relative to 2015 levels, in the probability of dying between 30 years and 70 years of age from cancers, cardiovascular diseases, chronic respiratory diseases, and diabetes by 2030-will be achieved in 35 countries (19%) for women, and 30 (16%) for men, if these countries maintain or surpass their 2010-2016 rate of decline in NCD mortality. Most of these are high-income countries with already-low NCD mortality, and countries in central and eastern Europe. An additional 50 (27%) countries for women and 35 (19%) for men are projected to achieve such a reduction in the subsequent decade, and thus, with slight acceleration of decline, could meet the 2030 target. 86 (46%) countries for women and 97 (52%) for men need implementation of policies that substantially increase the rates of decline. Mortality from the four NCDs included in SDG target 3.4 has stagnated or increased since 2010 among women in 15 (8%) countries and men in 24 (13%) countries. NCDs and age groups other than those included in the SDG target 3.4 are responsible for a higher risk of death in low-income and middle-income countries than in high-income countries. Substantial reduction of NCD mortality requires policies that considerably reduce tobacco and alcohol use and blood pressure, and equitable access to efficacious and high-quality preventive and curative care for acute and chronic NCDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(18)31992-5

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 113 references

Research works printed but not linked: 1

  1. Boseley, 2017, Threats, bullying, lawsuits: tobacco industry's dirty war for the African market, The Guardian

Cited by

Sorted by citations

Items 801–900 of 1,000

Related

See all

Metadata

Authors
Bennett, J. E., Stevens, G. A., Mathers, C. D., Bonita, R., Rehm, J., Kruk, M. E., Riley, L. M., Dain, K., Kengne, A. P., Chalkidou, K., Beagley, J., Kishore, S. P., Chen, W., Saxena, S., Bettcher, D. W., Grove, J. T., Beaglehole, R., & Ezzati, M.
Affiliations
  • Imperial College London (GB)
  • World Health Organization (CH)
  • University of Auckland (NZ)
  • University of Toronto (CA)
  • Harvard University (US)
  • Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Ezzati, Majid
ORCID
Venue
The Lancet
Publisher
Elsevier BV
Published
2018-09
Volume
392
Issue
10152
Pages
1072-1088
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(18)31992-5
OpenAlex
W2889654052
Cited by
1,336
References
113
Citations by year
2026: 114 · 2025: 206 · 2024: 222 · 2023: 190 · 2022: 207 · 2021: 189 · 2020: 131 · 2019: 69 · 2018: 8
FWCI
163.80
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Griffith Research Online (submittedVersion, cc-by-nc-nd)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
  • World Health Organization
  • Wellcome Trust
  • Medical Research Council (MR/R015600/1)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
Keywords
non-communicable diseases, NCD mortality, Sustainable Development Goal 3.4, mortality trends, cancer mortality, cardiovascular mortality, diabetes mortality, global burden of disease, age-standardized mortality rates, sex differences in mortality, low- and middle-income countries, sub-Saharan Africa, NCD prevention and control
MeSH terms
Global Burden of Disease, Noncommunicable Diseases, Age Factors, Alcohol Drinking, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, International Cooperation, Male, Neoplasms, Poverty Areas, Respiratory Tract Diseases, Risk Factors, Smoking, Suicide, Global Health, Sex Distribution, Mortality, Premature

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review